Robert Bedros - Richter Gedeon Member of the Supervisory Board
| GEDSFDelisted Stock | USD 19.45 0.00 0.00% |
Executive
Dr. Robert Jonathan Bedros has served as Member of the Supervisory Board of Chemical Works of Gedeon Richter Plc. since 2012. He is Physician, health economist, honorary associate professor. He is Head Physician and General Director of the Ministry of Interiors Central Hospital and Institutions from 1999 to 2005, and of Pest County Flor Ferenc Hospital from 2006 to 2011. Currently he serves as Head Physician and General Director of Szent Imre Hospital. He is also Member of the Audit Committee at the Company . He graduated from Semmelweis University of Medical Sciences. since 2012.
| Age | 56 |
| Tenure | 12 years |
| Professional Marks | Ph.D |
| Phone | 36 1 431 4000 |
| Web | https://www.richter.hu |
Richter Gedeon Management Efficiency
The company has return on total asset (ROA) of 0.0943 % which means that it generated a profit of $0.0943 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.247 %, meaning that it generated $0.247 on every $100 dollars invested by stockholders. Richter Gedeon's management efficiency ratios could be used to measure how well Richter Gedeon manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 10.71 K in total debt with debt to equity ratio (D/E) of 0.1, which may suggest the company is not taking enough advantage from borrowing. Richter Gedeon Vegyszeti has a current ratio of 3.23, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Richter Gedeon until it has trouble settling it off, either with new capital or with free cash flow. So, Richter Gedeon's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Richter Gedeon Vegyszeti sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Richter to invest in growth at high rates of return. When we think about Richter Gedeon's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Michael Joyce | Sun Life Financial | N/A | |
| David Garg | Sun Life Financial | N/A | |
| Mili Mathew | One Liberty Properties | 41 | |
| Larry Madge | Sun Life Financial | N/A | |
| Dianna Higgins | MGIC Investment Corp | N/A | |
| James Shaw | Montauk Renewables | 52 | |
| John Ciroli | Montauk Renewables | 52 | |
| Annette Adams | MGIC Investment Corp | N/A | |
| John III | NL Industries | 50 | |
| Danny GarciaVelez | MGIC Investment Corp | N/A | |
| Randolph Brown | Sun Life Financial | N/A | |
| Jane Grimm | NL Industries | 52 | |
| Alysa Block | One Liberty Properties | 63 | |
| Travis Smith | Eastman Chemical | N/A | |
| Shreyans Jain | MGIC Investment Corp | N/A | |
| Aishling Cullen | Sun Life Financial | N/A | |
| Mark JD | One Liberty Properties | 62 | |
| Kristin McCoy | NL Industries | 51 | |
| Adrian Holt | Eastman Chemical | 55 | |
| Anne Sonnen | Sun Life Financial | N/A | |
Management Performance
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0943 |
Richter Gedeon Vegyszeti Leadership Team
Elected by the shareholders, the Richter Gedeon's board of directors comprises two types of representatives: Richter Gedeon inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Richter. The board's role is to monitor Richter Gedeon's management team and ensure that shareholders' interests are well served. Richter Gedeon's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Richter Gedeon's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gergely Horvath, Director | ||
| Janos Csak, Member of the Executive Board | ||
| Christopher Long, Director | ||
| Jeno Fodor, Member of the Supervisory Board, Employee Representative | ||
| Szilveszter Vizi, Director | ||
| Gabor Toth, Member of the Supervisory Board, Employee Representative | ||
| Attila Szenasi, Member Board | ||
| Andras Rado, Deputy Managing Director for Production and Logistics, Member of the Executive Board | ||
| Gabor Gulacsi, Deputy Managing Director for Finance, Member of the Executive Board, Director | ||
| Klara Kovacsne, Member of the Supervisory Board, Employees' Representative | ||
| Gabor Orban, Chief Strategy Officer | ||
| Csaba Polacsek, Director | ||
| Istvn Greiner, Research Board | ||
| Tamas Szolyak, Member Board | ||
| Csaba Lantos, Director | ||
| Eva Kovacsne, Member of the Supervisory Board, Employees' Representative | ||
| Norbert Szivek, Director | ||
| Katalin Erdei, Member Board | ||
| Jonathan Bedros, Member of the Supervisory Board | ||
| Gbor Orbn, Member CEO | ||
| Laszlo Kovacs, Director | ||
| Attila Chikan, Chairman of the Supervisory Board | ||
| Tamasne Mehesz, Member of the Supervisory Board | ||
| Gyorgy Thaler, Director of Development, Member of the Executive Board | ||
| Istvan Greiner, Research Director | ||
| Istvan Hamecz, Member Director | ||
| Sandor Kovats, Director of Commercial Services, Member of the Executive Board | ||
| Lajos Kovacs, Director of Technical Services, Member of the Executive Board | ||
| Ilona Hardy, Director | ||
| Tibor Horvth, Commercial Board | ||
| Kriszta Zolnay, Member of the Executive Board | ||
| Erik Bogsch, CEO, Managing Director, Member of Executive Board and Director | ||
| Gabor Perjes, Director | ||
| Tibor Horvath, Commercial Director, Member of the Executive Board | ||
| Katalin Ordog, Head of Investor Relations Department | ||
| William Gelsey, Chairman of the Board | ||
| Robert Bedros, Member of the Supervisory Board |
Richter Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Richter Gedeon a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0943 | |||
| Profit Margin | 0.32 % | |||
| Current Valuation | 4.88 B | |||
| Shares Outstanding | 186.29 M | |||
| Price To Earning | 50.06 X | |||
| Gross Profit | 349.27 B | |||
| EBITDA | 351.82 M | |||
| Net Income | 139.63 B | |||
| Cash And Equivalents | 389.33 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Richter OTC Stock
If you are still planning to invest in Richter Gedeon Vegyszeti check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Richter Gedeon's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |